Cargando…
The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies
BACKGROUND: The association between immune-related adverse events (irAEs) and survival outcomes in patients with advanced melanoma receiving therapy with immune checkpoint inhibitors (ICIs) has not been well established, particularly in Asian melanoma. METHODS: We retrospectively reviewed 49 melanom...
Autores principales: | Wu, Chiao-En, Yang, Chan-Keng, Peng, Meng-Ting, Huang, Pei-Wei, Chang, Ching-Fu, Yeh, Kun-Yun, Chen, Chun-Bing, Wang, Chih-Liang, Hsu, Chao-Wei, Chen, I-Wen, Lin, Cheng-Tao, Ueng, Shir-Hwa, Lin, Gigin, Lin, Yu-Fen, Cheng, Chi-Yuan, Chang, John Wen-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579996/ https://www.ncbi.nlm.nih.gov/pubmed/33087090 http://dx.doi.org/10.1186/s12885-020-07508-7 |
Ejemplares similares
-
Immune Checkpoint Inhibitors for Advanced Melanoma: Experience at a Single Institution in Taiwan
por: Wu, Chiao-En, et al.
Publicado: (2020) -
Sentinel Lymph Node Biopsy Was Associated With Favorable Survival Outcomes For Patients With Clinically Node-Negative Asian Melanoma
por: Chang, John Wen-Cheng, et al.
Publicado: (2019) -
Utility of diffusion-weighted and contrast-enhanced magnetic resonance imaging in diagnosing and differentiating between high- and low-grade uterine endometrial stromal sarcoma
por: Huang, Yen-Ling, et al.
Publicado: (2019) -
The role of PD-L1 in the radiation response and clinical outcome for bladder cancer
por: Wu, Chun-Te, et al.
Publicado: (2016) -
Response to Brigatinib Targeted Therapy in Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 19 Deletion, T790M, and cis-C797S Triple Mutations: A Case Report
por: Chen, Zi-Wei, et al.
Publicado: (2022)